Special access to the 20 patients already on the drug per the anavex press release lol. Why aren't the S1 failures in your "DD" link including the chart that shows ananvex has ZERO benefit of anyone scoring less than 20 on the MMSE? I've posted several in the past especially the large Japanese S1 failed trials. Or even the study Anavex SAB member Cummings was part of it that shows M1 has zero impact on cognition. I'll go back later and add them as I have before and post on relevant boards when I get the time.
News 
Market Data 
Discover 
